Lymphocytopenia predicts shortened survival in myelodysplastic syndrome with ring sideroblasts (MDS-RS) but not in MDS/MPN-RS-T

Am J Hematol. 2022 Mar 1;97(3):E109-E112. doi: 10.1002/ajh.26448. Epub 2022 Jan 3.

Affiliations

¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 34961962
DOI: 10.1002/ajh.26448

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Disease-Free Survival
Female
Humans
Lymphopenia* / etiology
Lymphopenia* / mortality
Male
Middle Aged
Myelodysplastic Syndromes* / complications
Myelodysplastic Syndromes* / mortality
Retrospective Studies
Survival Rate